Yes, Pseudomonas is a gram-negative bacterium. Every species in the Pseudomonas genus stains pink (negative) on a Gram stain rather than purple (positive), which reflects a specific type of cell wall structure that has major implications for how these bacteria cause infections and resist antibiotics.
What “Gram-Negative” Means for Pseudomonas
The Gram stain is a basic lab test that divides nearly all bacteria into two camps based on how their outer layers are built. Gram-positive bacteria have a thick, single-layered wall that holds onto a purple dye. Gram-negative bacteria, including Pseudomonas, have a thinner inner wall wrapped in a second outer membrane that washes the purple dye away, leaving only a pink counterstain behind.
The cell envelope of Pseudomonas aeruginosa, the most clinically important species, has three distinct layers: an inner membrane, a thin structural layer called peptidoglycan, and an outer membrane made of proteins, fats, and a molecule called lipopolysaccharide (LPS). That outer membrane is the defining feature of gram-negative bacteria, and it acts as a physical barrier that blocks many antibiotics from entering the cell. LPS also triggers strong inflammatory responses in the human body, which is part of why gram-negative infections can become severe quickly.
Why This Classification Matters Clinically
Knowing that Pseudomonas is gram-negative immediately narrows the list of antibiotics that can work against it. Many common antibiotics, particularly those designed for gram-positive bacteria, simply cannot penetrate that outer membrane. Pseudomonas aeruginosa takes this a step further: it is naturally resistant to a wider range of drugs than most other gram-negative bacteria, thanks to a combination of built-in defenses and its ability to acquire new resistance over time.
The World Health Organization classifies carbapenem-resistant Pseudomonas aeruginosa as a “high priority” pathogen because of its resistance to last-line antibiotics, its high transmissibility in healthcare settings, and its association with significant mortality. In hospital surveillance studies, roughly 30% of Pseudomonas aeruginosa isolates showed resistance to carbapenems, one of the strongest antibiotic classes available.
How Pseudomonas Protects Itself
Beyond its gram-negative outer membrane, Pseudomonas aeruginosa has several additional survival strategies that make it exceptionally hard to eliminate. One of the most important is biofilm formation. Biofilms are structured communities of bacteria encased in a self-produced matrix of sugars, proteins, and DNA. Bacteria living inside a biofilm can tolerate antibiotic concentrations up to 1,000 times higher than free-floating bacteria of the same species.
Biofilm formation happens in stages. Individual cells first attach to a surface using tiny hair-like structures, then lock in permanently and begin multiplying into organized clusters. These clusters mature into complex three-dimensional structures. Eventually, some cells break free and drift to colonize new surfaces. This is how Pseudomonas spreads across medical devices like urinary catheters, implants, and contact lenses. The bacteria coordinate this entire process through chemical signaling between cells, adjusting their collective behavior based on population density.
Pseudomonas also produces dormant “persister” cells that essentially shut down their metabolism, making them invisible to antibiotics that target active cellular processes. It can even invade and replicate inside human cells, hiding from both the immune system and drug treatment.
Identifying Pseudomonas in the Lab
A Gram stain is usually the first step in identifying Pseudomonas. Under the microscope, it appears as pink, rod-shaped cells. But many bacteria are gram-negative rods, so additional tests help pin down the genus. One key differentiator is the oxidase test: Pseudomonas aeruginosa is oxidase-positive, which separates it from common gut bacteria like E. coli and Salmonella, which are oxidase-negative.
Pseudomonas aeruginosa also produces distinctive pigments that make it recognizable on culture plates. One called pyoverdine fluoresces yellow-green under ultraviolet light and helps the bacterium scavenge iron from its surroundings. Iron acquisition is not just a nutritional need; it directly triggers biofilm development and the production of toxins. A second pigment, pyocyanin, gives colonies a characteristic blue-green color and contributes to tissue damage during infection. The combination of a grape-like odor, blue-green pigment, and a positive oxidase test often allows experienced lab technicians to identify Pseudomonas aeruginosa before formal testing is complete.
Where Pseudomonas Infections Occur
Pseudomonas aeruginosa causes infections in the lungs, bloodstream, urinary tract, surgical wounds, and burn sites. It thrives in moist environments and is a persistent problem in hospitals, where it colonizes sinks, ventilators, and water systems. Patients at highest risk include those on mechanical ventilation, those with surgical wounds or burns, and people with weakened immune systems.
Chronic lung infections with Pseudomonas are a hallmark of cystic fibrosis. Once established in the lungs of a person with CF, the bacterium forms biofilms in the airways that are nearly impossible to fully eradicate. Its iron-scavenging pigments fuel ongoing inflammation that damages lung tissue over time, and one of its metal-binding compounds has been specifically linked to the persistent inflammatory response seen in CF lungs. Pseudomonas aeruginosa accounts for roughly 12% of all hospital-acquired infections in some surveillance studies, making it one of the most common causes of serious healthcare-associated illness.